Lisa Conroy

Lisa Conroy is the Director of Communications at Antidote. She is a seasoned health communications strategist dedicated to understanding the reasons people make the health choices they do, and determining what that means in terms of how scientific data should be communicated. Prior to her role at Antidote, Lisa ran the TEDMED Great Challenges program, a public health initiative funded by RWJF. She also has experience working in pharmaceutical public relations in the areas of respiratory diseases, oncology, and HIV. Lisa holds an MPH from Columbia and a BA in English and International Studies from Northwestern.

Press release: "Antidote Technologies Drives Patient Recruitment for Three Pivotal COVID-19 Clinical Trials"

Press release: "Antidote Technologies Spearheads Recruitment for a COVID Early Treatment Fund Clinical Trial Recently Featured on CBS Program 60 Minutes"

Press release: "Antidote Technologies named a top innovator in new book for pharma industry"

PharmaVOICE 100: "Laurent Schockmel, Creating Transformative Connections"

PharmaVOICE: "Bringing the Patient Voice into Clinical Trials"

Press release: "Antidote Technologies Unveils Smart COVID-19 Clinical Trial Search to Speed Up Treatment and Vaccine Research Worldwide"

Deloitte: "Intelligent clinical trials - Transforming through AI-enabled engagement"

Press Release: "Antidote Technologies' Report on Survey of 4,000 Patients Reveals How to Increase Diversity in Clinical Research"

Press Release: "Leading Industry Sales Professional Joins the Executive Team at Antidote"

Press Release: "Antidote Technologies’ Laurent Schockmel Recognized as a Top 40 Healthcare Transformer"